Valeant gives Pershing Square a seat on its board

(Reuters) - Valeant Pharmaceuticals International Inc (NYSE: VRX) (NYSE: VRX), under scrutiny for its accounting and business practices, said it had given shareholder Pershing Square Capital Management a seat on its board and added two additional directors.

Stephen Fraidin, a veteran Wall Street lawyer who is vice chairman at William Ackman's Pershing Square, has joined the board, along with Fred Eshelman and Thomas Ross, Valeant said.

Anders Lonner has stepped down as a director, the company said on Wednesday.

(Reporting by Ankur Banerjee in Bengaluru; Editing by Ted Kerr)

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• South Korea President Lee looking to open new era of AI in with global tech companies
• UN assembly approves mandate extension for rights chief, despite US warning
• Trump says he won't proceed with nuclear deal unless Saudis join Abraham Accords